These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

499 related items for PubMed ID: 12621507

  • 1. Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy.
    Eisen D, Essell J, Broun ER, Sigmund D, DeVoe M.
    Bone Marrow Transplant; 2003 Jan; 31(1):51-5. PubMed ID: 12621507
    [Abstract] [Full Text] [Related]

  • 2. Valacyclovir prophylaxis for the prevention of Herpes simplex virus reactivation in recipients of progenitor cells transplantation.
    Dignani MC, Mykietiuk A, Michelet M, Intile D, Mammana L, Desmery P, Milone G, Pavlovsky S.
    Bone Marrow Transplant; 2002 Feb; 29(3):263-7. PubMed ID: 11859400
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Oral valacyclovir versus intravenous acyclovir in preventing herpes simplex virus infections in autologous stem cell transplant recipients.
    Liesveld JL, Abboud CN, Ifthikharuddin JJ, Lancet JE, Wedow LA, Oliva J, Stamm CG, Nichols D.
    Biol Blood Marrow Transplant; 2002 Feb; 8(12):662-5. PubMed ID: 12523578
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy of valacyclovir vs acyclovir for the prevention of recurrent herpes simplex virus eye disease: a pilot study.
    Miserocchi E, Modorati G, Galli L, Rama P.
    Am J Ophthalmol; 2007 Oct; 144(4):547-51. PubMed ID: 17692271
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparative bioavailability of acyclovir from oral valacyclovir and acyclovir in patients treated for recurrent genital herpes simplex virus infection.
    Bras AP, Sitar DS, Aoki FY.
    Can J Clin Pharmacol; 2001 Oct; 8(4):207-11. PubMed ID: 11743593
    [Abstract] [Full Text] [Related]

  • 10. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.
    Zuckerman RA, Lucchetti A, Whittington WL, Sanchez J, Coombs RW, Zuñiga R, Magaret AS, Wald A, Corey L, Celum C.
    J Infect Dis; 2007 Nov 15; 196(10):1500-8. PubMed ID: 18008230
    [Abstract] [Full Text] [Related]

  • 11. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
    Sperling RS, Fife KH, Warren TJ, Dix LP, Brennan CA.
    Sex Transm Dis; 2008 Mar 15; 35(3):286-90. PubMed ID: 18157071
    [Abstract] [Full Text] [Related]

  • 12. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
    Fife KH, Warren TJ, Justus SE, Heitman CK, HS2100275 STUDY TEAM.
    Sex Transm Dis; 2008 Jul 15; 35(7):668-73. PubMed ID: 18461016
    [Abstract] [Full Text] [Related]

  • 13. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.
    Gupta R, Wald A, Krantz E, Selke S, Warren T, Vargas-Cortes M, Miller G, Corey L.
    J Infect Dis; 2004 Oct 15; 190(8):1374-81. PubMed ID: 15378428
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV.
    Warren T, Harris J, Brennan CA.
    Clin Infect Dis; 2004 Nov 01; 39 Suppl 5():S258-66. PubMed ID: 15494897
    [Abstract] [Full Text] [Related]

  • 15. Randomized comparison of oral valacyclovir and intravenous ganciclovir for prevention of cytomegalovirus disease after allogeneic bone marrow transplantation.
    Winston DJ, Yeager AM, Chandrasekar PH, Snydman DR, Petersen FB, Territo MC, Valacyclovir Cytomegalovirus Study Group.
    Clin Infect Dis; 2003 Mar 15; 36(6):749-58. PubMed ID: 12627359
    [Abstract] [Full Text] [Related]

  • 16. Valacyclovir in the treatment of facial herpes simplex virus infection.
    Laiskonis A, Thune T, Neldam S, Hiltunen-Back E.
    J Infect Dis; 2002 Oct 15; 186 Suppl 1():S66-70. PubMed ID: 12353189
    [Abstract] [Full Text] [Related]

  • 17. Valacyclovir for the prevention of cytomegalovirus infection after allogeneic stem cell transplantation: a single institution retrospective cohort analysis.
    Vusirikala M, Wolff SN, Stein RS, Brandt SJ, Morgan DS, Greer JP, Schuening FG, Dummer JS, Goodman SA.
    Bone Marrow Transplant; 2001 Aug 15; 28(3):265-70. PubMed ID: 11535994
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics and safety of extemporaneously compounded valacyclovir oral suspension in pediatric patients from 1 month through 11 years of age.
    Kimberlin DW, Jacobs RF, Weller S, van der Walt JS, Heitman CK, Man CY, Bradley JS.
    Clin Infect Dis; 2010 Jan 15; 50(2):221-8. PubMed ID: 20014952
    [Abstract] [Full Text] [Related]

  • 19. Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life.
    Handsfield HH, Warren T, Werner M, Phillips JA.
    Sex Transm Dis; 2007 Jun 15; 34(6):339-43. PubMed ID: 17065847
    [Abstract] [Full Text] [Related]

  • 20. Double-blind study comparing 2 dosages of valacyclovir hydrochloride for the treatment of uncomplicated herpes zoster in immunocompromised patients 18 years of age and older.
    Arora A, Mendoza N, Brantley J, Yates B, Dix L, Tyring S.
    J Infect Dis; 2008 May 01; 197(9):1289-95. PubMed ID: 18422441
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.